Developing Structure-Activity Relationships for N-Nitrosamine Activity.

Area of Science:

• Pharmaceutical chemistry
• Toxicology
• Regulatory science

Background:

• Detection of N-nitrosodimethylamine (NDMA) in drugs necessitates N-nitrosamine risk assessments for all pharmaceuticals.
• N-nitrosamines are classified as "cohort-of-concern" compounds due to their potent rodent carcinogenicity.
• Current acceptable intake limits rely on rodent carcinogenicity data and structure-activity relationship (SAR) analyses.

Purpose of the Study:

• To investigate improvements in SARs for more accurate prediction of N-nitrosamine carcinogenic potency.
• To develop mechanistically based SARs for predicting N-nitrosamine carcinogenic potency categories.
• To enhance methods for calculating acceptable intake limits for N-nitrosamines using mechanistic analogs.

Main Methods:

• Established an ad hoc workgroup of 23 companies and universities.
• Collected and reviewed available public experimental data on N-nitrosamine mutagenicity and carcinogenicity.
• Developed SARs consistent with reaction mechanisms to predict carcinogenic potency.

Main Results:

• Progress made towards developing mechanistically based SARs for N-nitrosamine risk assessment.
• Identified the importance of establishing dominant reaction mechanisms prior to analog selection for read-across.
• Proposed a framework for improving N-nitrosamine risk assessment through mechanistic SARs.

Conclusions:

• Mechanistically informed SARs are crucial for accurate N-nitrosamine carcinogenic potency prediction.
• Establishing the dominant reaction mechanism is a key first step in risk assessment.
• This collaborative effort advances the scientific and regulatory understanding of N-nitrosamine impurities.